Press releases

21 April, 2021
News
IR
English
Corporate Information
Other Corporate Information
Ziccum AB is actively supporting the WHO’s World Immunization Week 2021, this year with the theme ‘Vaccines Bring us Closer’. CEO Göran Conradson: “We’ll be attending meetings and policy events with vaccine bodies from...
19 April, 2021
News
IR
English
Corporate Information
Other Corporate Information
A ground-breaking new memorandum of understanding between CEPI (The Coalition for Epidemic Preparedness Innovations) and the African Union was signed following a prestigious two-day virtual event, attended by Ziccum, hosted by the Africa Centres for Disease...
26 March, 2021
News
IR
English
Corporate Information
Other Corporate Information
Dr Anton Löfgren is an industrial process engineer specialising in unit operations in pharma manufacturing. For four months he visited Ziccum to develop mathematical models of Ziccum’s LaminarPace vaccine air-drying methodology for future industrial...
24 March, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Aktieägarna i Ziccum AB (publ), org.nr 559107-9412, kallas härmed till årsstämma den 27 april 2021. Mot bakgrund av den extraordinära situation som råder till följd av covid-19-pandemin kommer Ziccum AB:s årsstämma...
23 March, 2021
News
IR
English
Regulatory
Listing Regulation
Report
Annual
(Lund, Sweden, 23 March 2021) Ziccum AB today announces that its Annual Report for 2020 is now available on the company’s website. For further information and to read the Full Report (in Swedish) please visit:: https://ziccum.com/investors/financial-reports/...
23 March, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
(Lund, sverige mars 23, 2021) Ziccum AB meddelar att bolagets årsredosvisning för 2020 nu finns tillgänglig på bolagets hemsida. För mer information vänligen besök: https://ziccum.com/investors/financial-reports/ Pressmeddelandet...
17 March, 2021
News
IR
English
Corporate Information
Other Corporate Information
Swedish vaccine innovation company ZICCUM AB has been accepted as a member of NIIMBL, the US National Institute for Innovation in Manufacturing Biopharmaceuticals. NIIMBL drives innovation and uptake of new technologies within biopharmaceutical manufacturing...
16 March, 2021
News
IR
English
Corporate Information
Other Corporate Information
“We welcome CEPI’s new global initiative to prepare for future pandemics” says Ziccum CEO Göran Conradson, “and in particular its commitment to providing significant funding towards new manufacturing innovation to help scale-up...
12 March, 2021
News
IR
English
Corporate Information
Other Corporate Information
A major two-day summit of the world's top pharma and public health sector players has ended with strong agreement that scale-up of vaccine manufacturing is an urgent priority for 2021 and 2022. The summit held on 8-9 March 2021 and accompanying landscape...
26 February, 2021
News
IR
English
Corporate Information
Other Corporate Information
As part of Ziccum’s strategy of actively reaching out to global vaccine policymakers worldwide, Ziccum CEO Göran Conradson has submitted formal feedback to the EU’s consultation for the European Health Emergency Preparedness and Response...
24 March, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Aktieägarna i Ziccum AB (publ), org.nr 559107-9412, kallas härmed till årsstämma den 27 april 2021. Mot bakgrund av den extraordinära situation som råder till följd av covid-19-pandemin kommer Ziccum AB:s årsstämma...
23 March, 2021
News
IR
English
Regulatory
Listing Regulation
Report
Annual
(Lund, Sweden, 23 March 2021) Ziccum AB today announces that its Annual Report for 2020 is now available on the company’s website. For further information and to read the Full Report (in Swedish) please visit:: https://ziccum.com/investors/financial-reports/...
23 March, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
(Lund, sverige mars 23, 2021) Ziccum AB meddelar att bolagets årsredosvisning för 2020 nu finns tillgänglig på bolagets hemsida. För mer information vänligen besök: https://ziccum.com/investors/financial-reports/ Pressmeddelandet...
11 February, 2021
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Yearend
Summary of year-end report, fourth quarter 2020 During the fourth quarter, Ziccum announced that it had carried out a pilot study on large-scale production of temperature-stable vaccines. The pilot study centred on a Fill and Finish facility (the last...
11 February, 2021
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Yearend
Sammanfattning av delårsrapporten - fjärde kvartalet 2020 Under fjärde kvartalet meddelade Ziccum att en pilotstudie på storskalig produktion av temperaturstabila vacciner har genomförts. Pilotstudien avser en Fill and finish-anläggning...
25 January, 2021
News
IR
English
Regulatory
MAR
Corporate Action
Other
Lund, January 25, 2021 -- Ziccum AB (publ) (‘Ziccum’) entered into an evaluation study agreement on 3 Oct 2019 with Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Based on positive...
25 January, 2021
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
Lund, 25 januari 2021. Ziccum AB (publ) (‘Ziccum’) ingick ett utvärderingsavtal 3 oktober 2019 med Janssen Vaccine & Prevention B.V., en av Janssens läkemedelsbolag som tillhör Johnson & Johnson. Baserat på de...
01 December, 2020
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Other
Ziccum AB (”Ziccum” eller ”Bolaget”) meddelar att handeln av Bolagets aktie på Nasdaq First North Growth Market inleds i dag under kortnamn ”ZICC” med ISIN SE0011415595. Göran Conradson, VD, kommenterar...
16 November, 2020
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Other
Ziccum AB will be delisted from Spotlight after close of the market on November 30, 2020. For more information, see the press release from the company. Information about the share: Shortname: ZICC ISIN-code: SE0011415595 Orderbook-ID: 4NG9 CFI...
11 November, 2020
News
IR
English
Regulatory
LHFI
Corporate Action
Other
Ziccum AB ("Ziccum" or "the Company") announces today, November 11, 2020, that it has received approval for admission to trade on the Nasdaq First North Growth Market. The first day of trading on the Nasdaq First North Growth Market...